View in EDS HTML Full Text PDF Full Text

A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients.

Saved in:
Bibliographic Details
Title: A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients.
Authors: de Jonge AV; Department of Hematology, Amsterdam UMC location VU, Amsterdam, The Netherlands. a.dejonge1@amsterdamumc.nl., van Werkhoven E; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Dinmohamed AG; Department of Hematology, Amsterdam UMC location VU, Amsterdam, The Netherlands.; Erasmus MC, Department of Public Health, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands., Nijland M; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands., Zwinderman AH; Department of Clinical Epidemiology, Biostatistics, and Bioinformatics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Bossuyt PM; Department of Clinical Epidemiology, Biostatistics, and Bioinformatics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Veldhuis MS; Department of Hematology, Amsterdam UMC location VU, Amsterdam, The Netherlands., Rutten EGGM; Department of Pathology, Amsterdam UMC location VU, Amsterdam, The Netherlands., Mous R; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands., Vermaat JSP; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands., Sandberg Y; Department of Internal Medicine, Maasstad Hospital, Rotterdam, The Netherlands., de Jongh E; Department of Hematology, Albert Schweitzer Ziekenhuis, Dordrecht, The Netherlands., Bilgin YM; Department of Internal Medicine, Adrz, Goes, The Netherlands., Boersma R; Department of Internal Medicine, Amphia Ziekenhuis, Breda, The Netherlands., Koene H; Department of Hematology, St Antonius Ziekenhuis, Nieuwegein, The Netherlands., Kersten MJ; Department of Hematology, Amsterdam UMC location VU, Amsterdam, The Netherlands., de Jong D; Department of Pathology, Amsterdam UMC location VU, Amsterdam, The Netherlands., Chamuleau MED; Department of Hematology, Amsterdam UMC location VU, Amsterdam, The Netherlands.
Source: Blood cancer journal [Blood Cancer J] 2023 May 22; Vol. 13 (1), pp. 85. Date of Electronic Publication: 2023 May 22.
Publication Type: Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37217463
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22de+Jonge+AV%22">de Jonge AV</searchLink>; Department of Hematology, Amsterdam UMC location VU, Amsterdam, The Netherlands. a.dejonge1@amsterdamumc.nl.<br /><searchLink fieldCode="AU" term="%22van+Werkhoven+E%22">van Werkhoven E</searchLink>; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Dinmohamed+AG%22">Dinmohamed AG</searchLink>; Department of Hematology, Amsterdam UMC location VU, Amsterdam, The Netherlands.; Erasmus MC, Department of Public Health, University Medical Center Rotterdam, Rotterdam, The Netherlands.; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Nijland+M%22">Nijland M</searchLink>; Department of Hematology, University Medical Center Groningen, Groningen, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Zwinderman+AH%22">Zwinderman AH</searchLink>; Department of Clinical Epidemiology, Biostatistics, and Bioinformatics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bossuyt+PM%22">Bossuyt PM</searchLink>; Department of Clinical Epidemiology, Biostatistics, and Bioinformatics, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Veldhuis+MS%22">Veldhuis MS</searchLink>; Department of Hematology, Amsterdam UMC location VU, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Rutten+EGGM%22">Rutten EGGM</searchLink>; Department of Pathology, Amsterdam UMC location VU, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Mous+R%22">Mous R</searchLink>; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Vermaat+JSP%22">Vermaat JSP</searchLink>; Department of Hematology, Leiden University Medical Center, Leiden, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Sandberg+Y%22">Sandberg Y</searchLink>; Department of Internal Medicine, Maasstad Hospital, Rotterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Jongh+E%22">de Jongh E</searchLink>; Department of Hematology, Albert Schweitzer Ziekenhuis, Dordrecht, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Bilgin+YM%22">Bilgin YM</searchLink>; Department of Internal Medicine, Adrz, Goes, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Boersma+R%22">Boersma R</searchLink>; Department of Internal Medicine, Amphia Ziekenhuis, Breda, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Koene+H%22">Koene H</searchLink>; Department of Hematology, St Antonius Ziekenhuis, Nieuwegein, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Kersten+MJ%22">Kersten MJ</searchLink>; Department of Hematology, Amsterdam UMC location VU, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22de+Jong+D%22">de Jong D</searchLink>; Department of Pathology, Amsterdam UMC location VU, Amsterdam, The Netherlands.<br /><searchLink fieldCode="AU" term="%22Chamuleau+MED%22">Chamuleau MED</searchLink>; Department of Hematology, Amsterdam UMC location VU, Amsterdam, The Netherlands.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101568469%22">Blood cancer journal</searchLink> [Blood Cancer J] 2023 May 22; Vol. 13 (1), pp. 85. <i>Date of Electronic Publication: </i>2023 May 22.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Comparative Study; Journal Article; Observational Study; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101568469 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2044-5385 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220445385%22">20445385 </searchLink><i>NLM ISO Abbreviation: </i>Blood Cancer J <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37217463
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41408-023-00854-2
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 85
    Titles:
      – TitleFull: A non-randomized risk-adjusted comparison of lenalidomide + R-CHOP versus R-CHOP for MYC-rearranged DLBCL patients.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: de Jonge AV
      – PersonEntity:
          Name:
            NameFull: van Werkhoven E
      – PersonEntity:
          Name:
            NameFull: Dinmohamed AG
      – PersonEntity:
          Name:
            NameFull: Nijland M
      – PersonEntity:
          Name:
            NameFull: Zwinderman AH
      – PersonEntity:
          Name:
            NameFull: Bossuyt PM
      – PersonEntity:
          Name:
            NameFull: Veldhuis MS
      – PersonEntity:
          Name:
            NameFull: Rutten EGGM
      – PersonEntity:
          Name:
            NameFull: Mous R
      – PersonEntity:
          Name:
            NameFull: Vermaat JSP
      – PersonEntity:
          Name:
            NameFull: Sandberg Y
      – PersonEntity:
          Name:
            NameFull: de Jongh E
      – PersonEntity:
          Name:
            NameFull: Bilgin YM
      – PersonEntity:
          Name:
            NameFull: Boersma R
      – PersonEntity:
          Name:
            NameFull: Koene H
      – PersonEntity:
          Name:
            NameFull: Kersten MJ
      – PersonEntity:
          Name:
            NameFull: de Jong D
      – PersonEntity:
          Name:
            NameFull: Chamuleau MED
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 22
              M: 05
              Text: 2023 May 22
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 2044-5385
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: Blood cancer journal
              Type: main
ResultId 1